MedTrace Logo

Prostate Conformal Cryotherapy

NCT00877682 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2018-01-31

No results posted yet for this study

Summary

The goal of this clinical research study is to learn if using cryotherapy to treat only the part of the prostate that contains cancer is an effective treatment for prostate cancer. The safety of this treatment will also be studied. Researchers also want to learn if treating only the part of the prostate with cancer causes less impact on your quality of life than other types of therapies.

Conditions

Interventions

PROCEDURE

Cryoablation

Under general anesthetic using ultrasonic guidance, freezing (cryoablation) portion of prostate.

Sponsors & Collaborators

  • Endocare, Inc.

    collaborator INDUSTRY

  • Gen-Probe, Incorporated

    collaborator INDUSTRY

  • FirmaMed

    collaborator UNKNOWN

  • Envisioneering Medical Technologies

    collaborator INDUSTRY

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • John F. Ward, MD · M.D. Anderson Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-06
Primary Completion
2018-01-14
Completion
2018-01-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00877682 on ClinicalTrials.gov